Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis

Published:2021-01-09 Issue:1 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol. Res. Perspect.

Author:

Dörks Michael¹^ORCID,Jobski Kathrin¹^ORCID,Herget‐Rosenthal Stefan²,Hoffmann Falk¹,Douros Antonios³⁴⁵^ORCID

Affiliation:

1. Department of Health Services Research Carl von Ossietzky University Oldenburg Oldenburg Germany

2. Department of Medicine Rotes Kreuz Hospital Bremen Germany

3. Departments of Medicine and Epidemiology McGill University Montreal QC Canada

4. Centre for Clinical Epidemiology Lady Davis Institute – Jewish General Hospital Montreal QC Canada

5. Institute of Clinical Pharmacology and Toxicology Charité‐Universitätsmedizin Berlin Berlin Germany

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.707

Reference8 articles.

1. Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor

2. FDA ‐ October ‐ December 2018: Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS). In 2018.

3. Aortic Dissection and Cardiac Dysfunction Emerged Coincidentally During the Long-Term Treatment with Angiogenesis Inhibitors for Metastatic Renal Cell Carcinoma

4. Potential sunitinib‐induced coronary artery and aortic dissections;Hatem R;Can J Cardiol,2017

5. Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report Database

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Celiac trunk aortic dissection induced by bevacizumab therapy for rectal cancer: A case report;Medicine;2024-07-12

2. Vascular Endothelial Growth Factor Inhibitors and the Risk of Aortic Aneurysm and Aortic Dissection;JAMA Network Open;2024-03-04

3. Aneurysm and Artery Dissection After Oral VEGFR-TKI Use in Adults With Cancer;JAMA Network Open;2023-11-29

4. Cardiovascular toxicities following the use of tyrosine kinase inhibitors in hepatocellular cancer patients: a retrospective, pharmacovigilance study;Expert Opinion on Drug Safety;2023-08-29

5. Aortic dissection induced by vascular endothelial growth factor inhibitors;Frontiers in Pharmacology;2023-06-22